Revisited role for mucus hypersecretion in the pathogenesis of copd

I. Cerveri, V. Brusasco

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the basic pathophysiological mechanisms remain largely unknown. On the basis of recent results from pathological studies and large clinical trials, the presence of airway inflammation does not seem to be sufficient to explain the complexity of the disease and the relatively poor response to treatment. It is probably time to abandon the concept of COPD as a unique disease and define, identify and treat the various aspects, which may differ between individuals. Among the different phenotypic distinctions, the classical distinction "chronic bronchitis" has mucus hypersecretion as the key presenting symptom. Its role in COPD has been the subject of an ongoing debate; however, it now appears to be being re-evaluated due to findings from recent epidemiological and pathological studies. In this context, the view that chronic mucus hypersecretion plays a secondary role in the pathogenesis of COPD should be abandoned and instead, drugs targeting mucus hypersecretion should be considered as a treatment option.

Original languageEnglish
Pages (from-to)109-112
Number of pages4
JournalEuropean Respiratory Review
Volume19
Issue number116
DOIs
Publication statusPublished - Jun 1 2010

Fingerprint

Mucus
Chronic Obstructive Pulmonary Disease
Chronic Bronchitis
Drug Delivery Systems
Epidemiologic Studies
Clinical Trials
Inflammation
Therapeutics

Keywords

  • Chronic obstructive pulmonary disease
  • Mucus hypersecretion

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Revisited role for mucus hypersecretion in the pathogenesis of copd. / Cerveri, I.; Brusasco, V.

In: European Respiratory Review, Vol. 19, No. 116, 01.06.2010, p. 109-112.

Research output: Contribution to journalArticle

@article{7f22bfae8a444f6f8fc5b72f961c894a,
title = "Revisited role for mucus hypersecretion in the pathogenesis of copd",
abstract = "Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the basic pathophysiological mechanisms remain largely unknown. On the basis of recent results from pathological studies and large clinical trials, the presence of airway inflammation does not seem to be sufficient to explain the complexity of the disease and the relatively poor response to treatment. It is probably time to abandon the concept of COPD as a unique disease and define, identify and treat the various aspects, which may differ between individuals. Among the different phenotypic distinctions, the classical distinction {"}chronic bronchitis{"} has mucus hypersecretion as the key presenting symptom. Its role in COPD has been the subject of an ongoing debate; however, it now appears to be being re-evaluated due to findings from recent epidemiological and pathological studies. In this context, the view that chronic mucus hypersecretion plays a secondary role in the pathogenesis of COPD should be abandoned and instead, drugs targeting mucus hypersecretion should be considered as a treatment option.",
keywords = "Chronic obstructive pulmonary disease, Mucus hypersecretion",
author = "I. Cerveri and V. Brusasco",
year = "2010",
month = "6",
day = "1",
doi = "10.1183/09059180.00002710",
language = "English",
volume = "19",
pages = "109--112",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "116",

}

TY - JOUR

T1 - Revisited role for mucus hypersecretion in the pathogenesis of copd

AU - Cerveri, I.

AU - Brusasco, V.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the basic pathophysiological mechanisms remain largely unknown. On the basis of recent results from pathological studies and large clinical trials, the presence of airway inflammation does not seem to be sufficient to explain the complexity of the disease and the relatively poor response to treatment. It is probably time to abandon the concept of COPD as a unique disease and define, identify and treat the various aspects, which may differ between individuals. Among the different phenotypic distinctions, the classical distinction "chronic bronchitis" has mucus hypersecretion as the key presenting symptom. Its role in COPD has been the subject of an ongoing debate; however, it now appears to be being re-evaluated due to findings from recent epidemiological and pathological studies. In this context, the view that chronic mucus hypersecretion plays a secondary role in the pathogenesis of COPD should be abandoned and instead, drugs targeting mucus hypersecretion should be considered as a treatment option.

AB - Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the basic pathophysiological mechanisms remain largely unknown. On the basis of recent results from pathological studies and large clinical trials, the presence of airway inflammation does not seem to be sufficient to explain the complexity of the disease and the relatively poor response to treatment. It is probably time to abandon the concept of COPD as a unique disease and define, identify and treat the various aspects, which may differ between individuals. Among the different phenotypic distinctions, the classical distinction "chronic bronchitis" has mucus hypersecretion as the key presenting symptom. Its role in COPD has been the subject of an ongoing debate; however, it now appears to be being re-evaluated due to findings from recent epidemiological and pathological studies. In this context, the view that chronic mucus hypersecretion plays a secondary role in the pathogenesis of COPD should be abandoned and instead, drugs targeting mucus hypersecretion should be considered as a treatment option.

KW - Chronic obstructive pulmonary disease

KW - Mucus hypersecretion

UR - http://www.scopus.com/inward/record.url?scp=77953177170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953177170&partnerID=8YFLogxK

U2 - 10.1183/09059180.00002710

DO - 10.1183/09059180.00002710

M3 - Article

C2 - 20956178

AN - SCOPUS:77953177170

VL - 19

SP - 109

EP - 112

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 116

ER -